1Bogdanovic AD, Gradimir M, Jankovic, et al. Apoptosis in bone marrow of myelodysplastic syndrome patients[J]. Blood,1996,87(7):3064.
2Alexandra E, Irvine M, Karen Magill, et al. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia[J]. Experimental Hematology, 1998,26: 435-439.
5Bouscary D, Vos JD, Guesnuin, et al. Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes[J]. Leukemia, 1997,11(6): 839-845.
6Kitagawa M, Yamayuchi S, Takashi M, et al. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasis[J]. Leukemia, 1998,12(4):486-492.
7Tsoplou P, Kourakli'-Symeonidis A, Thepoulou E, et al.Apoptosis in patients with myelodysplastic syndrome(MDS):differential involvement of marrow cells in early versus advanced cases and correlation with the expression of apoptosisrelated genes[J]. Blood, 1997,90(?):203a.
8Rajapaksa R, Ginzton N, Rott LS, et al. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells[J ]. Blood, 1996,88(11):4275-4287.
9Kentaro H, Nakakuma H, Kawaguchi T, et al. Apoptosis resistance of blood cells from patients with paroxysmal nactunal hemoglobinuria, aplasia anemia and myelodysplastic syndrome[J]. Blood, 1997,90(7):2716 2722.
10Haase D, Feurmg-Buske M, Schafer C, et al. Cytogenetic analysis of CD+34 supopulation in AML and MDS characterized by the expression of CD38 and CD117[J]. Leukemia, 1997, 11(5):674-679.
